Factors predictive of parametrial boost in patients with cervical cancer treated with definitive chemoradiation.

Gynecol Oncol Rep · 2022 · PMC8753115 · PMID 35036508

Europe PMC DOI

hedged sentences

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

showed a trendp = 0.054so close (0.05 < p ≤ 0.1)

Of note, increased EBRT treatment length also showed a trend toward statistical significance (OR 0.965, 95% CI 0.931–1.001, p = 0.054). 3.3.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Differences in treatment outcomes for those who did and did not receive PMB did not reach statistical significance in terms of pelvic recurrence, central tumor persistence, distant metastases, and median survival.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.